Dr. Red: Allopurinol Tablets 300mg Recall Due to Foreign Substance
Dr. Reddy's Laboratories recalls 300mg allopurinol tablets for foreign substance presence. Rx-only medication with NDC 55111-730-01. No remedy specified in official notice.
“Dr. Red: Allopurinol Tablets 300mg Recall Due to Foreign Substance.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/32633-dr-red-allopurinol-tablets-300mg-recall-due-to-foreign-substance. Based on FDA recall #D-0583-2024 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0583-2024%22&limit=1).
The FDA announced on June 7, 2024, that Dr. Reddy's Laboratories, Inc. voluntarily recalled Allopurinol Tablets, USP 300mg due to the presence of a foreign substance. The recall affects 20,520 units distributed in Illinois, Mississippi, and Ohio.
How to tell if you have it
Dr. Reddy's
Allopurinol Tablets, USP 300mg
100 Tablets per bottle
NDC 55111-730-01
Lot code L2300594
The hazard
The recall was issued because of the presence of a foreign substance in the Allopurinol Tablets. The FDA classified this as a Class II recall.
Context
GovInfoNow's records show Dr. Reddy's Laboratories, Inc. has 85 other recalls on record since April 9, 2012. Other recent recalls of similar products include Dr. Reddy's Varenicline Tablets Recall (Nov. 11, 2025), Dr. Reddy's Succinylcholine Chloride Injection Recall (Sept. 26, 2025), and Dr. Reddy's Omeprazole Capsules Recall (June 30, 2025). Other recent recalls of similar products include Bionpharma Divalproex Tablets Recall (June 26, 2026), Graviti Furosemide Tablets Recall (Jan. 10, 2026), and Taro Recalls Children's Ibuprofen Due to Foreign Substance (March 2, 2026).
How to tell if you have this one
Check for the product name 'Allopurinol Tablets, USP 300mg, 100 Tablets per bottle' with NDC 55111-730-01. The medication is prescription-only and manufactured by Dr. Reddy's Laboratories LA LLC in Shreveport, LA.
Brand
Dr. Reddy's
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Product Details
Verify the product name and NDC number (55111-730-01) to confirm if it's affected.
Where it went and when
Where it was distributed
Distributed in 3 states.
Listed by the agency
Not listed
FDA distribution: “IL, MS, OH” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Illinois, Mississippi, Ohio.
Recall timeline
FDA terminated this recall 18 months after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-0583-2024 (June 7, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0583-2024 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.